TFPI2, tissue factor pathway inhibitor 2, 7980

N. diseases: 161; N. variants: 5
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma
0.040 AlteredExpression disease BEFREE Differential expression of ANOS1 mRNA by GC cell lines correlated positively to levels of ITGAV, FOXC2 and NODAL mRNAs and inversely with those of TFPI2. 26270236 2016
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma
0.040 PosttranslationalModification disease BEFREE Methylation status of the TFPI2 gene was examined in primary carcinomas and the corresponding normal tissues derived from 38 patients with gastric cancer using quantitative methylation-specific PCR (qMSP) and the correlation between the methylation status and the clinicopathological findings was evaluated. 21036731 2010
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma
0.040 PosttranslationalModification disease BEFREE Aberrant methylation of TFPI2 promoter CpG island occurred not only in GC cells but also in primary GC tissues at a high frequency, suggesting that epigenetic silencing of TFPI2 may contribute to gastric carcinogenesis. 20113832 2010
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma
0.040 PosttranslationalModification disease BEFREE Multivariate analysis confirmed that TFPI2 methylation is a significant and independent prognostic factor in gastric carcinoma. 19195878 2009